P1281: REFRACTORY PATIENTS WITH FAVORABLE/INTERMEDIATE-RISK AML BENEFIT FROM AZACYTIDINE MAINTENANCE THERAPY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Xinhui Zheng,
Yigeng Cao,
Erlie Jiang
Affiliations
Xinhui Zheng
1 Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China
Yigeng Cao
2 Chinese Academy of Medical Sciences & Peking Union Medical College
Erlie Jiang
2 Chinese Academy of Medical Sciences & Peking Union Medical College
